Birth control is a blessing for people avoiding or delaying pregnancy However it is important to be aware of potential side ...

Evofem Biosciences (EVFM) announced that it has entered into a License and Supply Agreement with Windtree Therapeutics (WINT), under which ...

Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply ...

In other recent news, Windtree Therapeutics has entered into a License and Supply Agreement with Evofem Biosciences (OTC:EVFM) to serve as the sourcing partner for the contraceptive vaginal gel, ...

Women's health innovator Evofem Biosciences, Inc. , today announced financial results for the fourth quarter and year ended December 31, 2024. Highlights ...

1) The vast majority of 2024 net sales were contributed by PHEXXI® (lactic acid, citric acid, and potassium bitartrate) vaginal gel, Evofem's hormone-free, on demand contraceptive. Sales and ...

(NASDAQ:WINT), a biotechnology firm, has announced a License and Supply Agreement with Evofem Biosciences, Inc. (OTCQB:EVFM) to become the sourcing partner for the contraceptive vaginal gel, PHEXXI®.

(OTCQB: EVFM) for one of Evofem’s FDA-approved products -- PHEXXI ® (lactic acid, citric acid and potassium bitartrate). The product is a first-in-class hormone-free, on-demand prescription ...

A Pennsylvania-based biotech firm is already off to the races during Thursday’s premarket hours after the company announced that it has entered into a license and supply agreement to become a ...